Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 9694079 was granted and assigned to Heron Therapeutics on July, 2017 by the United States Patent and Trademark Office. | 9694079 | July 4, 2017 | |||||||
Patent 11413350 was granted and assigned to Heron Therapeutics on August, 2022 by the United States Patent and Trademark Office. | 11413350 | August 16, 2022 | |||||||
Patent 11744800 was granted and assigned to Heron Therapeutics on September, 2023 by the United States Patent and Trademark Office. | 11744800 | September 5, 2023 | |||||||
Patent 11878074 was granted and assigned to Heron Therapeutics on January, 2024 by the United States Patent and Trademark Office. | 11878074 | January 23, 2024 | |||||||
Patent 12115255 was granted and assigned to Heron Therapeutics on October, 2024 by the United States Patent and Trademark Office. | 12115255 | October 15, 2024 | |||||||
Patent 9561229 was granted and assigned to Heron Therapeutics on February, 2017 by the United States Patent and Trademark Office. | 9561229 | February 7, 2017 | |||||||
Patent 9808465 was granted and assigned to Heron Therapeutics on November, 2017 by the United States Patent and Trademark Office. | 9808465 | November 7, 2017 | |||||||
Patent 9913910 was granted and assigned to Heron Therapeutics on March, 2018 by the United States Patent and Trademark Office. | 9913910 | March 13, 2018 | |||||||
Patent 9592227 was granted and assigned to Heron Therapeutics on March, 2017 by the United States Patent and Trademark Office. | 9592227 | March 14, 2017 | |||||||
Patent 10357570 was granted and assigned to Heron Therapeutics on July, 2019 by the United States Patent and Trademark Office. | 10357570 | July 23, 2019 | |||||||
Patent 9801945 was granted and assigned to Heron Therapeutics on October, 2017 by the United States Patent and Trademark Office. | 9801945 | October 31, 2017 | |||||||
Patent 9913909 was granted and assigned to Heron Therapeutics on March, 2018 by the United States Patent and Trademark Office. | 9913909 | March 13, 2018 | |||||||
Patent 9446036 was granted and assigned to Heron Therapeutics on September, 2016 by the United States Patent and Trademark Office. | 9446036 | September 20, 2016 | |||||||
Patent 9744163 was granted and assigned to Heron Therapeutics on August, 2017 by the United States Patent and Trademark Office. | 9744163 | August 29, 2017 | |||||||
Patent 8715710 was granted and assigned to Heron Therapeutics on May, 2014 by the United States Patent and Trademark Office. | 8715710 | May 6, 2014 | |||||||
Patent 12115254 was granted and assigned to Heron Therapeutics on October, 2024 by the United States Patent and Trademark Office. | 12115254 | October 15, 2024 |